| Biomarker ID | 447 |
| PMID | 19505924 |
| Year | 2009 |
| Biomarker | CTC (Circulating Tumor Cells) |
| Biomarker Basis | Expression Based |
| Biomolecule | Others |
| Source | Blood |
| Subjects | Humans |
| Regulation | Increased expression in overall survival |
| Odds Ratio/Hazard Ratio/Relative Risk | Univariate: HR: 2.34 95% CI: (1.79-3.07); Multivariate: HR: 1.76 95% CI: (1.25-2.47) |
| Effect on Pathways | NA |
| Experiment | Overall Survival Vs No Survival |
| Type of Biomarker | Prognostic |
| Cohort | 100 patients with prostate cancer were selected to determine the overall survival for checkup after 26 months. 49 were dead after the study and 51 were alive. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | CellSearch CTC Assay |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | CTC |